Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT00557362

Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer (MUTT_TE)

Mycotic Ulcer Treatment Trial Therapeutic Exploratory Study

Sponsor: Aravind Eye Hospitals, India

Interventions Corneal de-epithelialization Natamycin 5% Voriconazole

Updated 8 times since 2017 Last updated: Jul 9, 2018 Started: Nov 30, 2007 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Fungal Keratitis, this trial is completed. The trial is conducted by Aravind Eye Hospitals, India and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

Sep 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Sep 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aravind Eye Hospitals, India
Dartmouth-Hitchcock Medical Center
That Man May See, Inc.
University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madurai, India
• Pondicherry, India